openPR Logo
Press release

AmeraCell Appoints Renowned Oncologist and Hematologist, Naveen Doki, MD, as Chief Medical Officer

01-09-2025 10:06 PM CET | Sports

Press release from: ABNewswire

AmeraCell Appoints Renowned Oncologist and Hematologist,

Image: https://lh7-rt.googleusercontent.com/docsz/AD_4nXf6lnWBjHtv1vNESJODCnyAI57Da6r_Bsny_CRL1HkRArIePBqhfHdc8E-3Mgv1srSjvPOZ0kOPN5esunTJVx31kwbLHZ4FGlGNuQxjEUfHP-Zx61Epyfu5917VDsN1YeM0FvdySA?key=pfjRRuJ_S4XBBGPHHK1PXqNz

New York New York - AmeraCell [https://ameracell.com/], a cutting-edge life science company, announced today the appointment of Naveen Doki, MD, as its Chief Medical Officer (CMO). Dr. Doki brings over a decade of experience in oncology and hematology from the DC Metro area to his new role.

As CMO, Dr. Doki will spearhead the development and implementation of AmeraCell's medical strategies, ensuring the company remains at the forefront of regenerative medicine and cellular therapies. His expertise will be instrumental in guiding AmeraCell's research and development initiatives.

"We are thrilled to welcome Dr. Doki to the AmeraCell team," said AJ Pakpour, CEO of AmeraCell. "His impressive clinical experience and passion for innovative therapies make him an ideal fit for our company. We look forward to his leadership in shaping the future of life science medicines."

Dr. Doki is a highly respected figure in the medical community, known as the doctors physician with a strong track record of delivering exceptional patient care. He has authored numerous publications and presented at various conferences, showcasing his expertise in oncology and hematology.

"I am excited to join AmeraCell and contribute to the company's mission to revolutionize healthcare through relief science medicines," said Dr. Doki. "I look forward to working with the talented team at AmeraCell to advance the field and improve patient outcomes."

About AmeraCell

AmeraCell [https://ameracell.com/] is a life science company dedicated to advancing regenerative medicine and cellular therapies. The company's innovative approach focuses on harnessing the power of stem cells and other cellular therapies to develop groundbreaking treatments for various diseases and conditions.

Contact:

AmeraCell

AmeracellClinics@gmail.com [mailto:AmeracellClinics@gmail.com]

407-801-2269

Note to editor:

- High-resolution images of Dr. Doki and the AmeraCell logo are available upon request.

- Interviews with Dr. Doki and AJ Pakpour can be arranged upon request.

Media Contact
Company Name: AmeraCell
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=ameracell-appoints-renowned-oncologist-and-hematologist-naveen-doki-md-as-chief-medical-officer]
Address:300 N Atlantic Ave #108
City: Cocoa Beach
State: FL 32931
Country: United States
Website: https://ameracell.com/



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AmeraCell Appoints Renowned Oncologist and Hematologist, Naveen Doki, MD, as Chief Medical Officer here

News-ID: 3809756 • Views:

More Releases from ABNewswire

Travel Expert Who Visited Every Sandals Resort Reveals 2025's Ultimate Rankings Following Major Industry Changes
Travel Expert Who Visited Every Sandals Resort Reveals 2025's Ultimate Rankings …
Pixie Honeymoons founder shares exclusive insights after completing comprehensive review of all 18 Sandals properties, including newly opened St. Vincent resort ATLANTA, GA - August 27, 2025 - Following significant changes in the Caribbean hospitality landscape and the opening of Sandals' newest property in St. Vincent, the award-winning team at Pixie Honeymoons - recognized as the #1 Beaches Resort Travel Agency in the United States and Top 10 Agency Worldwide at
The 2025 Definitive Guide: After 300+ Hours of Research, To Crown the Best NMN Supplement for Longevity
The 2025 Definitive Guide: After 300+ Hours of Research, To Crown the Best NMN S …
The NAD+ Revolution and the Demand for Scientific Certainty Nicotinamide Adenine Dinucleotide (NAD+) is not hype - it's the biochemical foundation for cellular health. Declines in NAD+ are directly linked to DNA damage, mitochondrial dysfunction, and accelerated aging. By age 50, your NAD+ levels may be less than half of what they were in youth. NMN (Nicotinamide Mononucleotide) is the most direct precursor to NAD+, while Resveratrol activates sirtuins - the "longevity
The Silent Epidemic: Navigating the Complexities of Sleep-Disordered Breathing and the Evolving Landscape of Treatment
The Silent Epidemic: Navigating the Complexities of Sleep-Disordered Breathing a …
In an era of heightened health awareness, a silent epidemic continues to affect millions worldwide: sleep-disordered breathing. This umbrella term for a group of conditions characterized by abnormal breathing patterns during sleep poses significant health risks, yet often goes undiagnosed. While effective treatments exist, recent headlines surrounding a major recall of a popular sleep apnea device have cast a spotlight on the challenges and advancements in managing this pervasive disorder.
Vibecode Blueprint Launching Sept 29 with Limited-Time Exclusive Bonus Package
Vibecode Blueprint Launching Sept 29 with Limited-Time Exclusive Bonus Package
Benjamin Hubner bundles AI GameBuilder GPT, SaaS toolkit, and mentorship for Vibecode Blueprint buyers. On September 29, the highly anticipated Vibecode Blueprint [https://www.quickprofitformulax.com/vibecode-blueprint-review-bonus-offer/] officially launches - and online entrepreneur Benjamin Hubner has announced a limited-time exclusive bonus package to support buyers in achieving faster, more profitable results. The Vibecode Blueprint is generating buzz as one of the most exciting releases of 2025, offering a easy to follow blueprint how to use vibe

All 5 Releases


More Releases for AmeraCell

AmeraCell Partners with StemWave to Offer Innovative Pain Management Solutions
Image: https://www.abnewswire.com/upload/2025/02/289e8b2e1d891a628fce90b1532c39f3.jpg Fairfax, VA - AmeraCell, a leading provider of life science medicines, is pleased to announce that it has signed a Letter of Intent (LOI) with StemWave, a pioneering provider of non-invasive pain management solutions. This strategic partnership aims to provide patients with cutting-edge regenerative medicine solutions for pain management, leveraging the expertise of both organizations. "We are thrilled to partner with StemWave to offer our patients innovative pain management options," said
AmeraCell Launches Revolutionary Wharton's Jelly MSc IV Therapy for Advanced Wel …
Image: https://www.abnewswire.com/upload/2025/01/9c6215166ea166a615398ac58e4d78ef.jpg Fairfax, Virginia - AmeraCell [https://ameracell.com/], a Life Science Clinic, is proud to announce the launch of its groundbreaking Wharton's Jelly MSc IV therapy. This innovative treatment utilizes the regenerative power of Wharton's jelly, cellular solutions, and mesenchymal cells to enhance overall wellness and address various chronic health conditions. Wharton's Jelly MSc therapy is derived from ethically sourced umbilical cords. It is rich in Wharton's jelly, growth factors, and other bioactive
01-21-2025 | Sports
ABNewswire
AmeraCell Bio Hacking with Wharton's Jelly IV Therapy
Image: https://www.abnewswire.com/upload/2025/01/4403872202ee73139f40540774e54535.jpg Fairfax Virginia - AmeraCell, [https://ameracell.com/]a leading provider of regenerative medicine solutions, is proud to announce the launch of its innovative Wharton's Jelly IV therapy. This groundbreaking treatment harnesses the power of mesenchymal stem cells (MSCs), cellular solutions, and exosomes to promote overall wellness and address various health conditions. About Wharton's Jelly IV Therapy Wharton's Jelly, a gelatinous substance extracted from umbilical cords, is rich in MSCs, growth factors, and other beneficial
AmeraCell Solidifies Leadership in Life Sciences with Plans for Innovation and E …
Image: https://www.abnewswire.com/upload/2025/01/362d0397e292acf147cd220e0ad40f81.jpg Washington, D.C. - January 2, 2025 - AmeraCell [https://ameracell.com/], a pioneering name in the life sciences sector, is proud to announce its continued success in 2024, solidifying its reputation as an industry leader. With a network of eight strategic locations across the United States, AmeraCell continues to redefine healthcare innovation and deliver exceptional patient outcomes. The company remains dedicated to improving lives through groundbreaking health solutions and personalized care. Reflecting
AmeraCell Accessible Affordable Bio Hacking in Katy Texas an American Life Scien …
Image: https://www.abnewswire.com/uploads/c46306625cd5028d1dcf9ba4de05042c.png Katy, TX - AmeraCell, a pioneering life science company, is thrilled to announce its expansion into Katy, Texas. This strategic move marks a significant milestone in AmeraCell's mission to democratize access to innovative, life-changing therapies. AmeraCell's Katy location will offer a comprehensive range of life science solutions, including: - Bio-Hacking: Personalized wellness programs leveraging cutting-edge technology and medical expertise - Stem Cell Therapy: MSC stem cell joint injections and IV hydration treatments
12-13-2024 | Sports
ABNewswire
AmeraCell Bio Hacking in Katy, Texas with Cutting-Edge Life Science Solutions
Image: https://www.abnewswire.com/uploads/79e38f5d5a8c3789b9f55057ecaf6d44.png Katy, TX - AmeraCell, a pioneering life science company, is thrilled to announce its expansion into Katy, Texas. This strategic move marks a significant milestone in AmeraCell's mission to democratize access to innovative, life-changing therapies. AmeraCell's Katy location will offer a comprehensive range of life science solutions, including: - Bio-Hacking: Personalized wellness programs leveraging cutting-edge technology and medical expertise - Stem Cell Therapy: MSC stem cell joint injections and IV hydration treatments